1492 Capital Management LLC Tyme Technologies, Inc. Transaction History

1492 Capital Management LLC

$164 Million
Q2 2024

Shares

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 10, 2022	SELL	$0.23 - $0.35 $447 - $681	-1,946 Reduced 1.22%	157,433 $44,000
Q1 2022 May 12, 2022	SELL	$0.28 - $0.68 $1,338 - $3,251	-4,782 Reduced 2.91%	159,379 $56,000
Q4 2021 Feb 14, 2022	SELL	$0.6 - $1.04 $1,920 - $3,328	-3,200 Reduced 1.91%	164,161 $99,000
Q3 2021 Nov 12, 2021	SELL	$0.99 - $1.38 $891 - $1,242	-900 Reduced 0.53%	167,361 $172,000
Q2 2021 Aug 13, 2021	SELL	$1.14 - $1.87 $1,899 - $3,115	-1,666 Reduced 0.98%	168,261 $212,000
Q1 2019 May 14, 2019	BUY	$1.76 - $3.73 $8,800 - $18,650	5,000 Added 3.03%	169,927 $299,000
Q4 2018 Feb 14, 2019	BUY	$2.01 - $4.21 $136,772 - $286,473	68,046 Added 70.24%	164,927 $609,000
Q2 2018 Aug 14, 2018	BUY	$2.05 - $4.09 $54,696 - $109,125	26,681 Added 38.01%	96,881 $306,000
Q1 2018 May 14, 2018	BUY	$2.12 - $7.0 $148,824 - $491,400	70,200 New	70,200 $157,000

About TYME TECHNOLOGIES, INC.

Ticker TYME
Exchange NASDAQ
Shares Outstandng 172,207,008
Description
Tyme Technologies, Inc., a biotechnology company, develops cancer metabolism-based therapies (CMBTs) in the United States. Its lead drug product is SM-88, a CMBT that is in a Phase II/III clinical trial to treat across 15 types of cancer, including pancreatic, prostate, breast, lung, glioma, ovarian, sarcoma, and colon. The company is also devel...

More about TYME

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of 1492 Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on 1492 Capital Management LLC with notifications on news.